Nurix Pharma - Wutah bathi EPS kuartalan NRIX

Logo korporat perusahaan Nurix Therapeutics, Inc. (NRIX)

High barriers to entry in the protein degradation sector and strict regulatory oversight protect the assets of Nurix Therapeutics (NRIX). The quarterly EPS trend profile visualizes current financial trends, where the 558.30 indicator determines the metric's magnitude. Partnerships with pharma behemoths strengthen the market moat, while the implementation of unique PROTAC molecules will provide the company with pricing power upon the success of lymphoma therapies.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan nurixtx.com (NRIX): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Nurix Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:nurixtx.com - NRIX
Barang unggulan nurixtx.com

This indicator measures the quarterly rate of change in earnings per share, reflecting the efficiency of capital generation. Growth in this metric signals business scaling, while stagnation warns of the risk of overpaying for the asset. By analyzing the quarterly earnings per share trend, an investor assesses the company's fundamental stability. For Nurix Therapeutics (NRIX), this figure is volatile due to a dependence on partner payments. Irregular cash inflows during the development of oncology drugs make cash flows difficult to predict.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Tyra Biosciences Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Verastem|GLUE (Monte Rosa Therapeutics) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CGEM: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IMRX (immuneering.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)